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exposed to sunlight and red spots appearing on 
the skin of the palms and the abdominal area. The 
results of physical examination were as follows: 
mental state was compos mentis, blood pressure 
was 120/70 mm Hg, pulse rate was 84 times/
minute, respiratory rate was 16 times/minute, and 
body temperature was 36.50C. The conjunctiva 
was not pale. There was no abnormality detected 
in ears, nose, and throat. On lung examination, the 
main respiratory sound was vesicular breathing 
in both lungs and there was no additional sound. 
On cardiologic examination, the heart border was 
normal, S1 and S2 were regular, and no murmur 
was detected. On abdominal examination, the 
abdomen was supple on palpation, the liver and 
spleen were not palpable, intestinal sound was 
normal on auscultation. Malar rash was seen on 
the facial skin while vasculitis was seen on the skin 
of the palmar area, thoracic area, upper abdominal 
area, volar upper arms, and lower extremities.
 
Figure 1   Malar rash of facial skin
Figure 2   Vasculitis of the thoracic and abdominal skin
According to the 1993 Association Research 
Circulation Osseous, idiopathic avascular necrosis 
of the femoral head is defi ned as the presence of 
disease or other causes that result in ischemic 
osteonecrosis of the femoral head without the 
presence of trauma or sepsis. Based on the 
above defi nition, idiopathic avascular necrosis 
(AVN) includes those that are the result of steroid 
administration, systemic lupus erythematosus, 
alcoholic consumption, etc. The pathogenesis 
of AVN is still obscure; however, it is basically 
caused by vascular circulation disorder, cell death 
and decreased capability of bone repair.1,2
Systemic lupus erythematosus (SLE) is 
characterized by the presence of systemic immune 
dysregulation, autoantibody formation, immune 
complex in the circulation, and activation of the 
systemic complement. The pathology during 
recurrence of SLE, among others, is the presence 
of vascular lesion in the form of infl ammation, 
thrombosis, endothelial injury in which the three 
of them are predispositions for atherosclerosis. 
The vascular lesion will cause microcirculation 
damage which is a risk factor for the occurrence of 
AVN in activation of SLE. Besides being caused 
by vascular lesion during activation of SLE, AVN 
is also triggered by fat deposition in SLE patients 
as a result of long term steroid therapy that causes 
abnormal blood fat level.1,2
Patients with SLE who have undergone 
pharmacologic treatment with systemic steroid 
either in oral or injection form will have 10 to 40 
times the risk of having idiopathic AVN. High dose 
of systemic steroid treatment of more than 4000 
mg of prednisone administered for more than three 
months or low dose of oral steroid administered for 
seven days can become a risk factor for AVN. The 
mechanism of AVN caused by steroid treatment 
is associated with hypercoagulation, fi brinolysis 
disorder, and thrombosis of the bone vein.1,2,3 We 
report a case of AVN of the right femoral head in 
an SLE patient.
CASE REPORT
A 29 year-old male has been diagnosed with 
SLE since 2006. During the last fi ve months of 
the follow up, the patient complained of pain 
of the right hip which worsened when walking 
and therefore causing a slight limp. The patient 
also complained of reddening of the face when 
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Figure 3   Vasculitis of the palms
 The results of the blood test were as follows: Hb level was 
16.7 g/ dl, leukocyte count was 9,200/ ul, platelet count was 
232,000/ ul, SGOT level was 33 U/L, SGPT level was 32 U/L, 
gamma GT was 26 U/L, serum alkaline phosphatase level was 
183 U/L, BUN level was 20 mg/ dl, serum creatinine level 
was 1.0 mg/ dl, BSN/ 2JPP: 72/85 mg/ dl, total cholesterol 
level was 152 mg/ dl, triglyceride level was 120 mg/ dl, HDL 
cholesterol level was 30 mg/ dl, LDL cholesterol level was 97 
mg/ dl, Na level was 137 mEq/ L, K level was 3.46 mEq/ L.
Figure 4   Pelvic photo: sclerotic and lytic lesions with irregular surface 
were found in the right femoral head. It was conclusive for avascular 
necrosis of the right femoral head
                
Figure 5   Pelvic MRI: the right femoral head deformity, sclerosis of the 
cortex, oedema of medulla, fl uid collection between right coxae joint. It 
was conclusive for avascular necrosis
The diagnoses established were SLE with involvement of 
the skin and vasculitis, and AVN of the right femoral head. 
The patient was then treated with 50 mg once per day of 
azathioprine, 4 mg twice per day of methyl prednisolone, 
500mg three times per day of CaCO3, 35 mg once per day of 
risedronate, and 80 mg once per day of acetylsalicylic acid. A 
total hip arthroplasty was later performed and resulted well.
DISCUSSION
Avascular necrosis is a disease that can occur in SLE. The 
incidence is between 5 to 80 percent. The risk factors of 
AVN, among others, are: steroid consumption either in high 
dose or in low dose administered for more than seven days, 
age, vasculitis, Raynaud’s phenomenon, thrombophlebitis, 
the presence of cardiopoline antibody, and increased activity 
of SLE.1-4 Glucocorticoid therapy is associated with the 
occurrence of AVN through the following mechanism: blood 
stasis, trabecular bone ischemia, and increased osteocyte 
apoptosis. It is still obscure whether the mechanism of AVN 
resulting from glucocorticoid therapy is associated with the 
formation of thrombosis and fat emboli.5 Oinuma et al reported 
that the onset of AVN in SLE patients undergoing a high dose of 
glucocorticoid therapy occurs usually during the fi rst month of 
therapy.6 The patient consumed a low dose of steroid routinely 
in order to control the SLE; however, the disease had become 
active since fi ve months prior to the detection of AVN with 
signs of recurrence of malar rash and vasculitis of the skin. 
In addition, there was another risk factor, that is, the patient 
experienced dyslipidemia prior to treatment using the statin 
group. The main pathogenesis of AVN is vascular injury and 
fat deposition. Vascular injury is manifested by vasculitis and 
probably fat deposition because the patient had experienced 
dyslipidemia.
 In order to establish the diagnosis of AVN, besides using 
clinical signs such as tenderness of the avascular necrotic 
bone area, radiographic or MRI examination should be 
performed. The laboratory examination result can not be used 
as a basis for the diagnosis. Based on the modifi ed Steinberg 
classifi cation, AVN of the femoral head is classifi ed into the 
following stages/grades:
1. Radiographic result is normal but MRI or bone scan shows 
mild to severe abnormality of the femoral head,
2. Radiographic result shows mild to severe changes of the 
femoral head which became radiolucent and sclerotic,
3. Radiographic result shows subchondral fracture-Crescent 
sign–and mild to severe abnormality of the femoral head,
4. Radiographic result shows subchondral fracture and 
levelling of the femoral head with mild to severe 
involvement of the femoral head,
5. Radiographic result shows narrowing of the joint and/or 
changes of the acetabulum,
6. Radiographic result shows severe degeneration
Involvement of the femoral head is mild if the percentage of 
involvement is 1 to 25%, moderate if it is 26 to 50%, or severe 
if it is more than 50% 1,2,7. Based on the above classifi cation, 
we can conclude that the patient had stage/grade 4 AVN of the 
femoral head.
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 The management of AVN depends on age, AVN stage/grade, 
occupation, and prior treatment. Basically, the management 
of AVN is to avoid the triggering factor by improving fat 
metabolism and blood circulation, to give treatment to prevent 
deterioration of the SLE, and to undergo surgery. The surgery 
performed - core decompression, valgus osteotomy, bone 
grafting - is for the mild or early stage/ grade while a total 
hip arthroplasty is performed for the severe and late stage/
grade.1,2,8-10 The patient is still given a low dose of steroid but 
in a much lower dose and then combined with azathioprine, 
statin therapy for managing dyslipidemia, acetylsalicylic acid, 
biphosphonate, and total hip arthroplasty.
SUMMARY
We report a 29 year-old SLE male patient who had complained 
of tenderness of the hip and right foot which caused a limp 
when walking, reddening of the facial skin, and appearance of 
red spots on the chest and abdominal skin since fi ve months 
ago. The patient was fi nally diagnosed with activated SLE 
with involvement of the skin and vasculitis, and AVN of the 
right femoral head. In addition to continuing the therapy to 
manage the SLE, a total hip arthroplasty was performed to 
treat AVN of the femoral head.
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